Literature DB >> 21377047

Giant phyllodes tumors of the breast: imaging findings with clinicopathological correlation in 14 cases.

Jin Chung1, Eun Ju Son, Jeong-Ah Kim, Eun-Kyung Kim, Jin Young Kwak, Joon Jeong.   

Abstract

PURPOSE: To describe imaging features in giant phyllodes tumors (GPTs) with radiology-pathologic correlations.
MATERIALS AND METHODS: Surgically confirmed 14 GPTs of the breast were retrospectively reviewed with ultrasound, mammograms, computed tomography, magnetic resonance imaging, and positron emission tomography.
RESULTS: The most GPTs showed circumscribed and lobulated masses with cystic necrosis. Five cases of core needle biopsy results were benign other than GPTs.
CONCLUSION: Radiology-pathologic correlation in GPTs is essential, due to differences of pathologic results (5/14 in our study) between core biopsy and surgical pathology.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21377047     DOI: 10.1016/j.clinimag.2010.01.004

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  3 in total

1.  Apatinib treatment is effective for metastatic malignant phyllodes tumors of the breast: a case report.

Authors:  Xiaolu Wang; Li Xie; Wenjing Hu; Jing Yan; Xiaoping Qian; Lijing Zhu
Journal:  BMC Womens Health       Date:  2021-05-22       Impact factor: 2.809

2.  Clinicopathology and treatment of a giant malignant phyllodes tumor of the breast: A case report and literature review.

Authors:  Wayne A Warner; Vandana Devika Sookdeo; Maurice Fortuné; Meenakshi Akhilesh; Chalapathi Rao Adidam Venkata; Wayne Mohammed; Cassandra Ramkissoon; Dave Harnanan; Lemuel Pran; Ravi Maharaj
Journal:  Int J Surg Case Rep       Date:  2017-10-04

3.  A rare case of malignant giant phyllodes tumour with retrosternal extension and pericardial invasion.

Authors:  Rishi Philip Mathew; Ram Shenoy Basti; Hadihally B Suresh
Journal:  BJR Case Rep       Date:  2016-05-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.